Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2015 | 04-2014 | 04-2013 | 04-2012 | 04-2011 | |
| Sales | 8,863 | 11,550 | 8,323 | 7,149 | 6,882 |
| Cost of Goods | 7,633 | 6,263 | 5,328 | 4,899 | 3,511 |
| Gross Profit | 1,230 | 5,287 | 2,995 | 2,250 | 3,371 |
| Operating Expenses | 15,101 | 11,810 | 9,544 | 12,214 | 9,117 |
| Operating Income | -13,238 | -6,260 | -6,221 | -9,065 | -5,235 |
| Other Income | 225 | -1,129 | -99 | 402 | 1,444 |
| Pre-tax Income | -13,013 | -7,389 | -6,320 | -8,663 | -3,791 |
| Income Tax | 127 | 17 | 10 | -2 | 11 |
| Net Income Continuous | -13,140 | -7,406 | -6,330 | -8,661 | -3,802 |
| Net Income | $-13,140 | $-7,406 | $-6,330 | $-8,661 | $-3,802 |
| EPS Basic Total Ops | -2.20 | -1.32 | -1.44 | -2.28 | -1.32 |
| EPS Basic Continuous Ops | -2.20 | -1.33 | -1.46 | -2.22 | -1.35 |
| EPS Diluted Total Ops | -2.20 | -1.32 | -1.44 | -2.28 | -1.32 |
| EPS Diluted Continuous Ops | -2.20 | -1.33 | -1.46 | -2.22 | -1.35 |
| EBITDA(a) | $-13,024 | $-6,047 | $-6,018 | $-8,960 | $-5,193 |